UNCONTROLLED GOUT
Clinical trials for UNCONTROLLED GOUT explained in plain language.
Never miss a new study
Get alerted when new UNCONTROLLED GOUT trials appear
Sign up with your email to follow new studies for UNCONTROLLED GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot may offer easier gout treatment without need for IV
Disease control Recruiting nowThis study tests if a shot under the skin (subcutaneous) of pegloticase works as well as the standard IV infusion for people with uncontrolled gout. Both groups also take methotrexate weekly. The goal is to lower uric acid levels below 6 mg/dL for most of the sixth month. About 2…
Matched conditions: UNCONTROLLED GOUT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New hope for tough gout cases: experimental combo targets stubborn uric acid
Disease control Recruiting nowThis study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…
Matched conditions: UNCONTROLLED GOUT
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC